HI SB446 | 2023 | Regular Session
Note: Carry Foward to future SB446
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on January 20 2023 - 25% progression, died in committee
Action: 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
Pending: Senate Ways and Means Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 20 2023 - 25% progression, died in committee
Action: 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
Pending: Senate Ways and Means Committee
Text: Latest bill text (Amended) [HTML]
Summary
Requires the Department of Health to conduct a study to determine the feasibility of implementing a pilot program to integrate prescription digital therapeutic products approved by the federal Food and Drug Administration in outpatient treatment programs for persons with substance use disorder and persons with opioid use disorder in the State. Requires a report to the Legislature. Effective 12/31/2050. (SD1)
Title
Relating To Prescription Digital Therapeutics.
Sponsors
| Sen. Jarrett Keohokalole [D] | Sen. Henry Aquino [D] | Sen. Chris Lee [D] | Sen. Angus McKelvey [D] |
| Sen. Les Ihara [D] | Sen. Glenn Wakai [D] |
Roll Calls
2023-02-06 - Senate - Senate Health and Human Services: Passed, With Amendments (Y: 4 N: 1 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-17 | Senate | Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM. |
| 2023-02-17 | Senate | Reported from HHS (Stand. Com. Rep. No. 459) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM. |
| 2023-02-06 | Senate | The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro; Aye(s) with reservations: none ; 1 No(es): Senator(s) Awa; and 0 Excused: none. |
| 2023-02-03 | Senate | The committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference. |
| 2023-01-25 | Senate | Referred to HHS, WAM. |
| 2023-01-20 | Senate | Passed First Reading. |
| 2023-01-20 | Senate | Introduced. |
Same As/Similar To
SB446 (Carry Over) 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
Subjects
Department of Health
Feasibility Study
Opioid Use Disorder
Outpatient Treatment
Pilot Program
Prescription Digital Therapeutics
Substance Use Disorder
Feasibility Study
Opioid Use Disorder
Outpatient Treatment
Pilot Program
Prescription Digital Therapeutics
Substance Use Disorder
